Molecular, histopathological, and clinical risk factors for overall metastatic disease and brain metastases in surgically resected stage I-III lung cancer.
Dyrbekk APH, Suhrke P, Ludahl MO, Zecic N, Moe JO, Eide IJZ, Lund-Iversen M, Brustugun OT
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.